| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/27/1999 | US5929043 Inhibiting copying of dna at target sequence in viable cell by introducing into said cell a pair of nucleoprotein filaments, where the filaments each comprise a ssdna strand coated with a recombinase, forming double d-loop |
| 07/27/1999 | US5929032 Method for treating Schwann and colon cells in vitro |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/27/1999 | US5928947 Mammalian multipotent neural stem cells |
| 07/27/1999 | US5928945 Bioreactor with substrate on which cells are attached, and means to apply shear stress of 1 to 100 dynes per square centimeter; enhances maintenance phenotype |
| 07/27/1999 | US5928943 Embryonal cardiac muscle cells, their preparation and their use |
| 07/27/1999 | US5928942 Hormone-secreting cells derived from pancreatic islet maintained in long-term culture |
| 07/27/1999 | US5928940 Morphogen-responsive signal transducer and methods of use thereof |
| 07/27/1999 | US5928939 Genetic engineering |
| 07/27/1999 | US5928938 Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof |
| 07/27/1999 | US5928937 Dna coding for acetohydroxy acid synthase enzyme modified by amino acid substitutions, deletions, or additions; confers resistance to pyrimidyl-oxy-benzoic acid, sulfamoylurea, and sulfonylcarboximide herbicides among others |
| 07/27/1999 | US5928928 For diagnosis of infections; for fungicides, antiprotozoa agents, antihelminthic agents; in body lotions, dentrifices, foods; for temporary implants; time-release agents |
| 07/27/1999 | US5928926 Isolation and cloning of the human ARSA-I gene and uses thereof |
| 07/27/1999 | US5928922 Proteins and polynucleotides used in the production of recombinant collagen |
| 07/27/1999 | US5928915 Nucleotide sequences that codes for a cytosolic enzyme from chinese hamster ovaries; diagnosis, antiflammatory agents; antiarthritic agents, antitubercular agents, and viricides |
| 07/27/1999 | US5928914 Methods and compositions for transforming cells |
| 07/27/1999 | US5928913 Herpes virus amplicon coding for antigen or immunomodulatory protein with replication-deficient helper herpes virus; for gene therapy and vaccines |
| 07/27/1999 | US5928899 Cell division regulators |
| 07/27/1999 | US5928898 Multiple drug resistance gene atrD of Aspergillus nidulans |
| 07/27/1999 | US5928895 IgA Fc binding protein |
| 07/27/1999 | US5928893 Monoclonal antibody specific for human 4-1BB and cell line producing same |
| 07/27/1999 | US5928874 Nek1-related protein kinase |
| 07/27/1999 | US5928639 Immunotherapy of cancer with allogeneic lymphocytes |
| 07/27/1999 | US5928469 Process for storage of materials |
| 07/27/1999 | CA2167520C Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 07/27/1999 | CA2071989C Endogenous gene expression modification with regulatory element |
| 07/27/1999 | CA2049056C Cell capsule extrusion systems |
| 07/27/1999 | CA2006454C Potatoe tuber specific transcriptional regulation |
| 07/27/1999 | CA1340675C Vaccines and diagnostics derived from bovine diarrhea virus |
| 07/23/1999 | CA2227827A1 In vitro artificial cornea and sclera |
| 07/22/1999 | WO1999036562A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | WO1999036554A1 An autoregulatory system for validating microbial genes as possible antimicrobial targets using a tetracycline-controllable element |
| 07/22/1999 | WO1999036550A2 Human protease molecules |
| 07/22/1999 | WO1999036549A1 Testis-specific human svph1-8 proteinase |
| 07/22/1999 | WO1999036542A1 Gene associated with disease resistance in plants |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036537A2 Fatty acid transport proteins |
| 07/22/1999 | WO1999036535A1 Apo-2 ligand |
| 07/22/1999 | WO1999036531A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells |
| 07/22/1999 | WO1999036530A2 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | WO1999036528A2 Transgenic non-human mammal, a method for the production thereof, and the utilization thereof |
| 07/22/1999 | WO1999036519A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME |
| 07/22/1999 | WO1999036516A2 Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host |
| 07/22/1999 | WO1999036512A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | WO1999036511A2 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | WO1999036508A1 Histidine kinase |
| 07/22/1999 | WO1999036438A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM |
| 07/22/1999 | WO1999036436A1 FATTY ACID SYNTHASE mRNA BINDING PROTEIN |
| 07/22/1999 | WO1999036433A2 Materials and methods for treating oncological disease |
| 07/22/1999 | WO1999036432A2 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999028483A3 Isolation and characterization of plant regulatory sequences |
| 07/22/1999 | WO1999027958A3 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 07/22/1999 | WO1999025814B1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
| 07/22/1999 | WO1999023208A3 RIBOZYMES TARGETED TO IL-15 mRNA |
| 07/22/1999 | WO1999012971A3 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 07/22/1999 | WO1999005291A3 Aggrecan degrading metallo proteases |
| 07/22/1999 | DE19801780A1 Transgenic non-human mammal containing p53 knock-in gene, useful as model for carcinogenesis |
| 07/22/1999 | DE19801120A1 New orotidine-5'-phosphate decarboxylase gene useful as selectable marker for microbial transformation |
| 07/22/1999 | CA2318664A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | CA2318662A1 Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host |
| 07/22/1999 | CA2318660A1 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | CA2318575A1 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318363A1 Fatty acid transport proteins |
| 07/22/1999 | CA2317838A1 Testis-specific human svph1-8 proteinase |
| 07/22/1999 | CA2317392A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | CA2317094A1 Human protease molecules |
| 07/22/1999 | CA2315299A1 Fatty acid synthase mrna binding protein |
| 07/21/1999 | EP0930366A2 Binding domains in delta proteins |
| 07/21/1999 | EP0930365A2 Binding domains in serrate protein |
| 07/21/1999 | EP0930362A2 Method of synchronizing epithelial cells into Go phase |
| 07/21/1999 | EP0930361A1 Cell compositions |
| 07/21/1999 | EP0930009A1 Quiescent cell population for nuclear transfer |
| 07/21/1999 | EP0929809A1 Process and device for in vitro diagnosis of allergic disorders |
| 07/21/1999 | EP0929689A2 Artifical chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 07/21/1999 | EP0929687A1 Mammary gland-specific promoters |
| 07/21/1999 | EP0929684A2 Phospholipase d and dna sequences |
| 07/21/1999 | EP0929680A1 Thermostable dna polymerase from carboxydothermus hydrogenoformans |
| 07/21/1999 | EP0929677A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1 |
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929672A1 Human gtp binding protein gamma-3 |
| 07/21/1999 | EP0929670A1 P-selectin ligand proteins |
| 07/21/1999 | EP0929668A1 Modulators of brca1 activity |
| 07/21/1999 | EP0929665A1 Cell-based drug screens for regulators of gene expression |
| 07/21/1999 | EP0929664A1 Hematopoietic stem cells and methods for generating such cells |
| 07/21/1999 | EP0929663A1 Method of increasing growth and yield in plants |
| 07/21/1999 | EP0929662A1 Cell culture media for mammalian cells |
| 07/21/1999 | EP0929661A1 Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics |
| 07/21/1999 | EP0929579A1 Monoclonal antibodies against a human act and serine protease complex |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929575A1 Novel human growth factors |
| 07/21/1999 | EP0929573A1 Methods for the isolation and proliferation of insulin-secreting cells |
| 07/21/1999 | EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 07/21/1999 | EP0929564A1 High level expression of proteins |
| 07/21/1999 | EP0929311A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS |
| 07/21/1999 | EP0929306A1 Method of inhibiting smooth muscle cell proliferation |
| 07/21/1999 | EP0929271A1 Prosthetic kidney and its use for treating kidney disease |
| 07/21/1999 | EP0929211A1 THE PROMOTER (FLt) FOR THE FULL-LENGTH TRANSCRIPT OF PEANUT CHLOROTIC STREAK CAULIMOVIRUS (PC1SV) |
| 07/21/1999 | EP0594576B1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |